Search results
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Zacks via Yahoo Finance· 2 months agoIt was a busy week for the biotech sector with lots of study data readouts and regulatory approvals....
Biotech Stock Roundup: GERN Surges on Study Data, PHAT, VERA Offer Updates & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, Geron...
Geron (GERN) Up on Imetelstat Data on Myelodysplastic Syndromes
Zacks via Yahoo Finance· 1 year agoGeron (GERN) posts positive top-line data from the phase III IMerge study investigating its lead...
7 A-Rated Stocks to Buy for Less Than $25
InvestorPlace via Yahoo Finance· 1 year agoThe overall stock market may be demonstrating resilience, but as uncertainty continues to run high, stocks have only made a modest, partial recovery....
Company News for Mar 18, 2024
Zacks via Yahoo Finance· 2 months agoGeron Corporation's GERN shares jumped 92% after an FDA advisory panel voted in favor of its blood disorder treatment, imetelstat. Shares of Apple Inc....
Radius (RDUS) to Go Private With $890M Deal, Shares Gain
Zacks via Yahoo Finance· 2 years agoRadius Health RDUS recently announced that it has entered into a definitive agreement to be acquired...
Buy These 2 Beaten-Down Stocks, Goldman Sachs Says, Forecasting up to 130% Upside
TipRanks via Yahoo Finance· 8 months agoThe Federal Reserve might have completed its round of rate hikes, based on recent statements made by...
2 Top Healthcare Stocks to Buy Right Now
Motley Fool· 1 year agoGeron Corporation (NASDAQ: GERN) and Idexx Laboratories (NASDAQ: IDXX) are both poised to grow and make great long-term healthcare investments, but for...
Why Shares of Geron Are Up 30% This Week
Motley Fool· 1 year agoShares of Geron (NASDAQ: GERN), a clinical-stage biotech company, were up more than 30% this week before CEO John A. Scarlett's scheduled appearance at...
Mirati (MRTX) Up on Positive Data From NSCLC Study on Adagrasib
Zacks via Yahoo Finance· 2 years agoShares of Mirati Therapeutics, Inc. MRTX were up 36.45% on Jun 7 after the company announced...